BIOINFORMATICS SHARED RESOURCE The Bioinformatics SR (BIOIN) is a vital component of the Center?s entire research operation. It houses all databases, date storage, and analytic infrastructure central to Lineberger?s research. Two major functions of the SR are 1) the maintenance of all databases, substantial computational and data storage infrastructure in a secure yet utilitarian computing environment and; 2) a full complement of research services to faculty for ?big data? analysis and the development of new analytic techniques. An example of these services includes the management of the Laboratory Information Management System (LIMS) used for tissue tracking which promotes the seamless transfer of samples from group to group. The LIMS integrates with other applications such as the Lineberger Data & Biospecimens Repository and Tableau for report generation. LIMS currently supports 10 SR, encompassing 7,628 active protocols, and 2.5M containers. The SR is central to the handling and analysis of tissue-based clinical genomics studies such as UNCsequel and those 9 institutional trials. The facility is a primary partner for faculty in sequencing processes for DNA and RNA and drive new tools for discovery and results in publications such as Perou & Parker, Bioinformatics 2019,and Kim et al. Nat Methods, 2018) Another example is the involvement of BIOIN in every TCGA paper since 2016 (48 in total). BIOIN request a CCSG budget of $264,702 which represents 8% of its operating costs and is requested to support the salary of key personnel for effort in support of cancer research and bioinformatic analysis. This facility was used by nearly 100 members for bioinformatics analysis in fiscal year 2019. The facility is a Lineberger exclusive resource and as such the users were 100% members in 2019. The import of the core and its scientific infrastructure is illustrated by the ~$3.5M annual LCCC investment in its operation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016086-45
Application #
10089831
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-06-01
Project End
2025-11-30
Budget Start
2020-12-01
Budget End
2021-11-30
Support Year
45
Fiscal Year
2021
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Moschos, Stergios J; Sullivan, Ryan J; Hwu, Wen-Jen et al. (2018) Development of MK-8353, an orally administered ERK1/2 inhibitor, in patients with advanced solid tumors. JCI Insight 3:
Brosnan, Evelyn M; Anders, Carey K (2018) Understanding patterns of brain metastasis in breast cancer and designing rational therapeutic strategies. Ann Transl Med 6:163
Valle, Carmina G; Queen, Tara L; Martin, Barbara A et al. (2018) Optimizing Tailored Communications for Health Risk Assessment: A Randomized Factorial Experiment of the Effects of Expectancy Priming, Autonomy Support, and Exemplification. J Med Internet Res 20:e63
Sun, Junjiang; Shao, Wenwei; Chen, Xiaojing et al. (2018) An Observational Study from Long-Term AAV Re-administration in Two Hemophilia Dogs. Mol Ther Methods Clin Dev 10:257-267
Wilczewski, Caralynn M; Hepperla, Austin J; Shimbo, Takashi et al. (2018) CHD4 and the NuRD complex directly control cardiac sarcomere formation. Proc Natl Acad Sci U S A 115:6727-6732
Waters, Andrew M; Der, Channing J (2018) KRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer. Cold Spring Harb Perspect Med 8:
Cai, Ling; Tsai, Yi-Hsuan; Wang, Ping et al. (2018) ZFX Mediates Non-canonical Oncogenic Functions of the Androgen Receptor Splice Variant 7 in Castrate-Resistant Prostate Cancer. Mol Cell 72:341-354.e6
Au, Kin Man; Tripathy, Ashutosh; Lin, Carolina Pe-I et al. (2018) Bespoke Pretargeted Nanoradioimmunotherapy for the Treatment of Non-Hodgkin Lymphoma. ACS Nano 12:1544-1563
Mirlekar, Bhalchandra; Michaud, Daniel; Searcy, Ryan et al. (2018) IL35 Hinders Endogenous Antitumor T-cell Immunity and Responsiveness to Immunotherapy in Pancreatic Cancer. Cancer Immunol Res 6:1014-1024
Buist, Diana S M; Abraham, Linn; Lee, Christoph I et al. (2018) Breast Biopsy Intensity and Findings Following Breast Cancer Screening in Women With and Without a Personal History of Breast Cancer. JAMA Intern Med 178:458-468

Showing the most recent 10 out of 1525 publications